<i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways
<i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways is a paper indexed in ScholarIQ from OpenAlex.
How many citations does <i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways have?
<i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways has 66 citations in the OpenAlex counts ScholarIQ stores.
When was <i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways published?
<i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways has 1998 year in the ScholarIQ index.
What is the open-access status of <i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways?
<i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways has green oa status in the ScholarIQ index.
What is the DOI of <i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways?
The DOI for <i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways is on the source record.
What is the PMID of <i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways?
The PMID for <i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways is on the source record.
What is the OpenAlex record for <i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways?
The OpenAlex for <i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways is on the source record.